Market Research Future

Precision Medicine Market Quadruples by 2022 at a 12.48% Of Whooping CAGR; Asserts MRFR

This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the Global Precision Medicine Market over the forecast period.


Pune, India -- (SBWIRE) -- 01/03/2018 -- The Global Precision Medicine Market report titled "Precision Medicine Market Research Report-Forecast to 2022? is a specialist investigation report by Market Research Future includes broad essential research alongside the definite examination of subjective and additionally quantitative perspectives by different industry specialists, key sentiment pioneers to pick up a more profound understanding of the market and industry execution. Considering all these factors the global Precision Medicine market research report was valued at $38.92 billion in 2015, and is expected to reach $88.64 billion by 2022. Thus the market is expected to perform a growth at a CAGR of 12.48% from 2015 to 2022.

Market Research Future published new report, titled "Precision Medicine Market -Research Report: Global Forecast to 2022".

Competition in the Global Precision Medicine Market and are profiled in MRFR Analysis. "Global Precision Medicine Market by Manufacturers, Countries, Type and Application, Forecast to 2022 Report "Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments.

Major Players are: Abbott., Almac Group, Asuragen, Inc., bioMérieux SA, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ab-Biotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh are some of the Prominent Players at the forefront of competition in the global precision medicine market and are profiled in MRFR Analysis.

Global Precision Medicine Market – Overview:

The global precision medicine market is growing with rapid pace, mainly due to the increasing number of patient involvement in personal healthcare. According to a recent study report published by the Market Research Future, the global precision medicine market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a spectacular growth by 2022, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017–2022).

The market is going to continue with the same trends of growth during the forecast period. The major drivers will be the advancements in the healthcare, technology, increasing prevalence of the genetic diseases, and rising integration of big data healthcare companies with pharmaceutical & biotech companies. In 2016, according to the Centres for Disease Control and Prevention, it was estimated that genetic disease like sickle cell anaemia affected approximately 100 million Americans. Additionally, potential for targeted therapies fuels the market growth. However, potential threat to personal data, high diagnostic cost, and stringent regulations and standards restrains the market growth during the forecast period. The healthcare data software developers are on a stand-by from the FDA regarding future compliance requirements and policies. Some precision medicine applications might face problems in future for timely transmission of critical health data between the doctor and the patient due to a vulnerability to deliberate 'Denial of Service' (DOS) attacks. To overcome this, in 2014, FDA published 'Content of Premarket Submissions for Management of Cyber security in Medical Devices' which contains guidelines for the healthcare industry.

Global precision medicine market – competitive Analysis:

Characterized by the presence of several well-established and small players, the global precision medicine market appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Abbott is one of the significant players in the global precision medicine market. It is constantly expanding its strategy of the acquisition, merger, collaboration and product launches, as result the company's net revenue have increased from USD 20,405 million in 2015 to USSD 20,853 million in 2016. Significantly, the R&D expenditures was approximately around 7.0% in 2016.

In October, 2016, Abbott collaborated with Celgene and Agios for diagnostic identification of IDH mutations. Moreover, Celgene signed an agreement with Abbott to develop and commercialize the diagnostic tests.

In April, 2016, Abbott received FDA approval for its companion diagnostics Vysis CLL FISH probe kit in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients.

In May, 2016, Almac Group partnered with ZYMtronix on a National Science foundation sponsored project which focusrd on the stabilisation and immobilisation of metabolic enzymes for various applications in bio-oxidation.

In November, 2016 bioMérieux SA launched, eMAG, for molecular biology providing a platform for the extraction of nucleic acids including the DNA and RNA.


Global Precision Medicine Market – Regional Analysis:

The Americas leads global precision medicine market due to the advancement of gene mapping technologies and increasing precision medicine solutions. Moreover, with the announcement of Precision Medicine Initiative by President Barak Obama, this market has gain lots of attention. The Americas is followed by Europe. Countries like the U.K, France, Germany, Russia, the Netherlands, Spain, Finland, and Italy within the region are extensively involved in development of precision medicine solutions. The Asia Pacific is the fastest growing region due to a huge patient population and rising healthcare expenditure. On the other hand, Middle East & Africa have the least share of the market.

Major Table of Contents:

Chapter 1 Report Scope

Chapter 2 Executive Summary

Chapter 3 Market Overview

Chapter 4 Market Dynamics

Chapter 5 Industry Dynamics

Chapter 6 Consortiums, Certification, Regulations, and Standards

Chapter 7 Global Precision Medicine Market by Ecosystem Players

Chapter 8 Global Precision Medicine Market by Sub-Markets

Chapter 9 Global Precision Medicine Market by Therapeutics

Chapter 10 Global Precision Medicine Market by Geography

Chapter 11 Company Profile


Table 1 Leading Companies In The Precision Medicine Market 37
Table 2 Downsizing Cost Of Genome Sequencing 74
Table 3 Factors Impacting The Buyer's Bargaining Power 80
Table 4 Factors Impacting The Supplier's Bargaining Power 81
Table 5 Factors Impacting The Threat From Substitute 82


Figure 1 Precision Medicine Market Study 27
Figure 2 Research Methodology 29
Figure 3 Different Phases Of Research Methodology For The Global Market 30
Figure 4 Precision Medicine Market: Research Methodology 32
Figure 5 Global Precision Medicine Market Share, By Ecosystem, 2014-2022 ($Billion) 38


About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312